These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 18814284)

  • 1. Case study and application of process analytical technology (PAT) towards bioprocessing: II. Use of ultra-performance liquid chromatography (UPLC) for making real-time pooling decisions for process chromatography.
    Rathore AS; Wood R; Sharma A; Dermawan S
    Biotechnol Bioeng; 2008 Dec; 101(6):1366-74. PubMed ID: 18814284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case study and application of process analytical technology (PAT) towards bioprocessing: use of on-line high-performance liquid chromatography (HPLC) for making real-time pooling decisions for process chromatography.
    Rathore AS; Yu M; Yeboah S; Sharma A
    Biotechnol Bioeng; 2008 Jun; 100(2):306-16. PubMed ID: 18078292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case study and application of process analytical technology (PAT) towards bioprocessing: Use of tryptophan fluorescence as at-line tool for making pooling decisions for process chromatography.
    Rathore AS; Li X; Bartkowski W; Sharma A; Lu Y
    Biotechnol Prog; 2009; 25(5):1433-9. PubMed ID: 19725111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large scale demonstration of a process analytical technology application in bioprocessing: use of on-line high performance liquid chromatography for making real time pooling decisions for process chromatography.
    Rathore AS; Parr L; Dermawan S; Lawson K; Lu Y
    Biotechnol Prog; 2010; 26(2):448-57. PubMed ID: 19927320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Process analytical technology (PAT) for biopharmaceutical products: Part II. Concepts and applications.
    Read EK; Shah RB; Riley BS; Park JT; Brorson KA; Rathore AS
    Biotechnol Bioeng; 2010 Feb; 105(2):285-95. PubMed ID: 19731253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Process analytical technology (PAT) for biopharmaceutical products: Part I. concepts and applications.
    Read EK; Park JT; Shah RB; Riley BS; Brorson KA; Rathore AS
    Biotechnol Bioeng; 2010 Feb; 105(2):276-84. PubMed ID: 19731252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomanufacturing process analytical technology (PAT) application for downstream processing: Using dissolved oxygen as an indicator of product quality for a protein refolding reaction.
    Pizarro SA; Dinges R; Adams R; Sanchez A; Winter C
    Biotechnol Bioeng; 2009 Oct; 104(2):340-51. PubMed ID: 19472303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A demonstration of the use of ultra-performance liquid chromatography-mass spectrometry [UPLC/MS] in the determination of amphetamine-type substances and ketamine for forensic and toxicological analysis.
    Apollonio LG; Pianca DJ; Whittall IR; Maher WA; Kyd JM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 836(1-2):111-5. PubMed ID: 16617037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Process Analytical Technology (PAT): batch-to-batch reproducibility of fermentation processes by robust process operational design and control.
    Gnoth S; Jenzsch M; Simutis R; Lübbert A
    J Biotechnol; 2007 Oct; 132(2):180-6. PubMed ID: 17559961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-line process control of gradient elution liquid chromatography.
    Schweitz L; Fransson M; Karlsson L; Torstensson A; Johansson E
    Anal Chem; 2004 Aug; 76(16):4875-80. PubMed ID: 15307800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of UPLC for the determination of phenolic compounds and furanic derivatives in Brandy de Jerez.
    Schwarz M; Rodríguez MC; Guillén DA; Barroso CG
    J Sep Sci; 2009 Jun; 32(11):1782-90. PubMed ID: 19479772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemometrics-based process analytical technology (PAT) tools: applications and adaptation in pharmaceutical and biopharmaceutical industries.
    Challa S; Potumarthi R
    Appl Biochem Biotechnol; 2013 Jan; 169(1):66-76. PubMed ID: 23138336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAT for vaccines: the first stage of PAT implementation for development of a well-defined whole-cell vaccine against whooping cough disease.
    Streefland M; van de Waterbeemd B; Happé H; van der Pol LA; Beuvery EC; Tramper J; Martens DE
    Vaccine; 2007 Apr; 25(16):2994-3000. PubMed ID: 17313999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Process analytical technology (PAT) for biopharmaceutical products.
    Rathore AS; Bhambure R; Ghare V
    Anal Bioanal Chem; 2010 Sep; 398(1):137-54. PubMed ID: 20480150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of HPLC as an Enabler of Process Analytical Technology in Process Chromatography.
    Tiwari A; Kateja N; Chanana S; Rathore AS
    Anal Chem; 2018 Jul; 90(13):7824-7829. PubMed ID: 29847937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving drug manufacturing with process analytical technology.
    Rodrigues LO; Alves TP; Cardoso JP; Menezes JC
    IDrugs; 2006 Jan; 9(1):44-8. PubMed ID: 16374733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical and experimental comparison of mobile phase consumption between ultra-high-performance liquid chromatography and high performance liquid chromatography.
    Chen S; Kord A
    J Chromatogr A; 2009 Aug; 1216(34):6204-9. PubMed ID: 19616783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quality by design study applied to an industrial pharmaceutical fluid bed granulation.
    Lourenço V; Lochmann D; Reich G; Menezes JC; Herdling T; Schewitz J
    Eur J Pharm Biopharm; 2012 Jun; 81(2):438-47. PubMed ID: 22446063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of partially porous particle columns for the routine, generic analysis of biological samples for pharmacokinetic studies in drug discovery by reversed-phase ultra-high performance liquid chromatography-tandem mass spectrometry.
    Mallett DN; Ramírez-Molina C
    J Pharm Biomed Anal; 2009 Jan; 49(1):100-7. PubMed ID: 19019615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-benefit evaluation of on-line high-performance liquid chromatography analysis for pooling decisions in large-scale chromatography.
    Kaltenbrunner O; Lu Y; Sharma A; Lawson K; Tressel T
    J Chromatogr A; 2012 Jun; 1241():37-45. PubMed ID: 22560704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.